Anti-ELOVL2 monoclonal antibody

Pre-made anti-ELOVL2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ELOVL2/ELOVL2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0746-Ab-1/ GM-Tg-hg-IP0746-Ab-2Anti-Human ELOVL2 monoclonal antibodyHuman
GM-Tg-rg-IP0746-Ab-1/ GM-Tg-rg-IP0746-Ab-2Anti-Rat ELOVL2 monoclonal antibodyRat
GM-Tg-mg-IP0746-Ab-1/ GM-Tg-mg-IP0746-Ab-2Anti-Mouse ELOVL2 monoclonal antibodyMouse
GM-Tg-cynog-IP0746-Ab-1/ GM-Tg-cynog-IP0746-Ab-2Anti-Cynomolgus/ Rhesus macaque ELOVL2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0746-Ab-1/ GM-Tg-felg-IP0746-Ab-2Anti-Feline ELOVL2 monoclonal antibodyFeline
GM-Tg-cang-IP0746-Ab-1/ GM-Tg-cang-IP0746-Ab-2Anti-Canine ELOVL2 monoclonal antibodyCanine
GM-Tg-bovg-IP0746-Ab-1/ GM-Tg-bovg-IP0746-Ab-2Anti-Bovine ELOVL2 monoclonal antibodyBovine
GM-Tg-equg-IP0746-Ab-1/ GM-Tg-equg-IP0746-Ab-2Anti-Equine ELOVL2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0746-Ab-1/ GM-Tg-hg-IP0746-Ab-2; GM-Tg-rg-IP0746-Ab-1/ GM-Tg-rg-IP0746-Ab-2;
GM-Tg-mg-IP0746-Ab-1/ GM-Tg-mg-IP0746-Ab-2; GM-Tg-cynog-IP0746-Ab-1/ GM-Tg-cynog-IP0746-Ab-2;
GM-Tg-felg-IP0746-Ab-1/ GM-Tg-felg-IP0746-Ab-2; GM-Tg-cang-IP0746-Ab-1/ GM-Tg-cang-IP0746-Ab-2;
GM-Tg-bovg-IP0746-Ab-1/ GM-Tg-bovg-IP0746-Ab-2; GM-Tg-equg-IP0746-Ab-1/ GM-Tg-equg-IP0746-Ab-2
Products NameAnti-ELOVL2 monoclonal antibody
Formatmab
Target NameELOVL2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ELOVL2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0746-Ag-1Recombinant multi-species ELOV2/ ELOVL2/ SSC2 protein


    Target information

    Target IDGM-IP0746
    Target NameELOVL2
    Gene ID54898,54326,498728,703030,488219,101093184,615756,100063624
    Gene Symbol and SynonymsELOVL2,SSC2
    Uniprot AccessionQ9NXB9,D4A612
    Uniprot Entry NameELOV2_HUMAN,ELOV2_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000197977
    Target ClassificationN/A

    The target: ELOVL2, gene name: ELOVL2, also named as SSC2. Enables fatty acid elongase activity. Involved in fatty acid elongation, polyunsaturated fatty acid and very long-chain fatty acid biosynthetic process. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.